BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  Lipocine Inc. Testosterone Therapy Meets Phase 3 Goals

  September 24, 2014

   · 

  7 min read
• Business

  Leadership Upheaval At Delcath Systems, Inc. Includes $628,000 Golden Parachute

  September 24, 2014

   · 

  1 min read
• Business

  Eutropics Pharmaceuticals Signs $1.5M NCI Contract To Develop Predictive Diagnostic Tests For Guiding Acute Myeloid Leukemia Treatments

  September 24, 2014

   · 

  2 min read
• BioCrea Announces Upcoming Presentations At Leading International Conferences

  September 24, 2014

   · 

  3 min read
• Business

  Surgical Startup Minerva Surgical Inc. Nabs $25 Million For Ablation Device That Reduces Menstrual Bleeding

  September 24, 2014

   · 

  1 min read
• Policy

  Medunik Canada Announces Health Canada Priority Review Of PHEBURANE® Indicated For The Treatment Of Urea Cycle Disorders (UCD)

  September 24, 2014

   · 

  3 min read
• Pharm Country

  Helius Medical Technologies Announces Pilot Study For PoNS™

  September 24, 2014

   · 

  1 min read
• BioCapital

  Fibrocell And Intrexon Advance GM-HDF-COL7 Toward Clinical Development For The Treatment Of Recessive Dystrophic Epidermolysis Bullosa

  September 24, 2014

   · 

  1 min read